Evidence map›Paper›PMID 37563287›Full record

ArticleScientific reports2023

Transcriptomic clock predicts vascular changes of prodromal diabetic retinopathy.

Huishi Toh, Alexander Smolentsev, Ryan Sadjadi, Dennis Clegg, Jingqi Yan, Ron Stewart, James A Thomson, Peng Jiang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Huishi TohNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA.
Alexander SmolentsevNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA.
Ryan SadjadiNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA.
Dennis CleggNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA.
Jingqi YanDepartment of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, USA.
Ron StewartMorgridge Institute For Research, Madison, WI, 53706, USA.
James A ThomsonNeuroscience Research Institute, University of California Santa Barbara, Santa Barbara, CA, USA.
Peng JiangDepartment of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, USA. p.jiang@csuohio.edu.
University of California, Santa Barbara · USCleveland State University · USMorgridge Institute for Research · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy is a common complication of long-term diabetes and that could lead to vision loss. Unfortunately, early diabetic retinopathy remains poorly understood. There is no effective way to prevent or treat early diabetic retinopathy until patients develop later stages of diabetic retinopathy. Elevated acellular capillary density is considered a reliable quantitative trait present in the early development of retinopathy. Hence, in this study, we interrogated whole retinal vascular transcriptomic changes via a Nile rat model to better understand the early pathogenesis of diabetic retinopathy. We uncovered the complexity of associations between acellular capillary density and the joint factors of blood glucose, diet, and sex, which was modeled through a Bayesian network. Using segmented regressions, we have identified different gene expression patterns and enriched Gene Ontology (GO) terms associated with acellular capillary density increasing. We developed a random forest regression model based on expression patterns of 14 genes to predict the acellular capillary density. Since acellular capillary density is a reliable quantitative trait in early diabetic retinopathy, and thus our model can be used as a transcriptomic clock to measure the severity of the progression of early retinopathy. We also identified NVP-TAE684, geldanamycin, and NVP-AUY922 as the top three potential drugs which can potentially attenuate the early DR. Although we need more in vivo studies in the future to support our re-purposed drugs, we have provided a data-driven approach to drug discovery.

Indexed as

Diabetes MellitusDiabetic RetinopathyAnimalsBayes TheoremMurinaeRetinal VesselsTranscriptome

Identifiers

PMID37563287
PMCPMC10415264
OpenAlexW4385723761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.